Clinical features of Wee1 kinase-positive human hepatocellular carcinoma

被引：0
|
作者：
Kogiso, Tomomi [1 ]
Nagahara, Hikaru [2 ]
Tokushige, Katsutoshi [1 ]
Taniai, Makiko [1 ]
Torii, Nobuyuki [1 ]
Kodama, Kazuhisa [1 ]
Matsushita, Noriko [1 ]
Hashimoto, Etsuko [1 ]
Yamamoto, Masakazu [3 ]
Shiratori, Keiko [1 ]
机构：
[1] Tokyo Womens Med Univ, Dept Internal Med, Inst Gastroenterol, Tokyo, Japan
[2] Aoyama Hosp, Tokyo, Japan
[3] Tokyo Womens Med Univ, Dept Surg, Inst Gastroenterol, Tokyo, Japan
来源：
HEPATOLOGY | 2012年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
612
引用
收藏
页码：487A / 487A
页数：1
相关论文
共 50 条
  • [41] Cdc5 interacts with the Wee1 kinase in budding yeast
    Bartholomew, CR
    Woo, SH
    Chung, YS
    Jones, C
    Hardy, CFJ
    MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (15) : 4949 - 4959
  • [42] Targeting the WEE1 kinase as a molecular targeted therapy for gastric cancer
    Kim, Hye-Young
    Cho, Yunhee
    Kang, HyeokGu
    Yim, Ye-Seal
    Kim, Seok-Jun
    Song, Jaewhan
    Chun, Kyung-Hee
    ONCOTARGET, 2016, 7 (31) : 49902 - 49916
  • [43] Activation Domain-dependent Degradation of Somatic Wee1 Kinase
    Owens, Laura
    Simanski, Scott
    Squire, Christopher
    Smith, Anthony
    Cartzendafner, Jeff
    Cavett, Valerie
    Busby, Jennifer Caldwell
    Sato, Trey
    Ayad, Nagi G.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (09) : 6761 - 6769
  • [44] Wee1 Kinase: A Potential Target to Overcome Tumor Resistance to Therapy
    Esposito, Francesca
    Giuffrida, Raffaella
    Raciti, Gabriele
    Puglisi, Caterina
    Forte, Stefano
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (19)
  • [45] Down-Regulation of Wee1 Kinase by a Specific Subset of microRNA in Human Sporadic Pituitary Adenomas
    Butz, Henriett
    Liko, Istvan
    Czirjak, Sandor
    Igaz, Peter
    Khan, Mohammed Munayem
    Zivkovic, Vladimir
    Balint, Katalin
    Korbonits, Marta
    Racz, Karly
    Patocs, Attila
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (10): : E181 - E191
  • [46] A Wee1 kinase inhibitor, MK-1775, sensitizes cervical carcinoma cell lines to cisplatin and topotecan
    Shumway, Stuart D.
    Kubica, Jamie L.
    Guertin, Amy D.
    Hurd, Melissa S.
    Wexler, Roseanne S.
    Demuth, Tim
    Toniatti, Carlo
    CANCER RESEARCH, 2011, 71
  • [47] Pharmacodynamic evaluation of pCDC2 and Wee1 signature as biomarkers of target engagement for the Wee1 tyrosine kinase inhibitor MK-1775
    Cheng, J. D.
    Tibes, R.
    Schellens, J. H.
    Shapiro, G. I.
    Pavlick, A. C.
    Oza, A. M.
    Xu, Y.
    Song, Y.
    Lam, R. L. H.
    Demuth, T.
    EJC SUPPLEMENTS, 2010, 8 (07): : 202 - 202
  • [48] Wee1 Kinase Inhibitor AZD1775 Radiosensitizes Hepatocellular Carcinoma Regardless of TP53 Mutational Status Through Induction of Replication Stress
    Cuneo, Kyle C.
    Morgan, Meredith A.
    Davis, Mary A.
    Parcels, Leslie A.
    Parcels, Joshua
    Karnak, David
    Ryan, Caila
    Liu, Na
    Maybaum, Jonathan
    Lawrence, Theodore S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 95 (02): : 782 - 790
  • [49] Combination therapy targeting Rb/Wee1 kinase pathways for rhabdomyosarcoma treatment
    Kiany, Simin
    Huang, Gangxiong
    Justice, Melanie
    Keyomarsi, Khandan
    Kleinerman, Eugenie
    CANCER RESEARCH, 2018, 78 (13)
  • [50] RESCUE FROM GRANZYME B-INDUCED APOPTOSIS BY WEE1 KINASE
    CHEN, G
    SHI, LF
    LITCHFIELD, DW
    GREENBERG, AH
    JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (06): : 2295 - 2300
12345